The successful creation of functional new-to-nature viruses designed by artificial intelligence has prompted renewed calls for stronger oversight of synthetic biology and AI-enabled genome design. In the EU, meanwhile, discussions are focussed on preventing the malicious misuse of biotechnology, while paying little attention to the biosafety questions raised by increasingly capable AI genome design tools.









